HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

Autor: François Cherifi, Angélique Da Silva, Alison Johnson, Cécile Blanc-Fournier, Olivia Abramovici, Antonin Broyelle, Christelle Levy, Djelila Allouache, Ioana Hrab, Carine Segura, Adeline Morel, Maud Villemin, Clémence Boscher, Coraline Dubot-Poitelon, Pauline Rottier, Justine Lequesne, George Emile

Publikováno v: BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)

Abstract Background HER2 expression has a prognostic and predictive impact in early-stage breast cancer (BC). HER2 positive BC (immunohistochemistry (IHC) score 3 + or 2 + with in situ hybridization (ISH) amplification) are treated with HER2 targeted

Externí odkaz: https://doaj.org/article/729e7bcb52cf4560a57a3e58bf74b4ff

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

Autor: Bruno Poulet, Alexander Valent, Jean-Pierre Ghnassia, Gaëtan MacGrogan, Lounes Djerroudi, Véronique Becette, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Olivia Abramovici, Marie-Mélanie Dauplat, Cécile Blanc-Fournier, Yves Marie Robin, Agnès Leroux, Isabelle Treilleux, Frédérique Penault-Llorca, Elisabeth Russ, Paul Delrée, Eva Brabencova, Magali Lacroix-Triki, Pascal Roger, Juliette Haudebourg, Martine Antoine, Anca Berghian, Véronique Verriele, Patrick Michenet, Raphaëlle Duprez-Paumier, Marie-Pierre Chenard, Clémence Fleury, Anne Vincent-Salomon, Camille Franchet, Laurent Arnould, Lucie Tixier, Pour le Gefpics, Marie-Christine Mathieu

Publikováno v: Annales de Pathologie
Annales de Pathologie, Elsevier Masson, 2021, ⟨10.1016/j.annpat.2021.07.014⟩

The last international guidelines on HER2 determination in breast cancer have been updated in 2018 by the American Society of Clinical Oncology and College of American Pathologists, on the basis of a twenty-year practice and results of numerous clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292f83395888c73d5447eb356730dcd1
https://hal.archives-ouvertes.fr/hal-03333764

[Neuroendocrine tumors of the breast: Myth or reality? A systematic review]

Autor: Claire, Cheymol, Olivia, Abramovici, Christine, Do Cao, Aurélie, Dumont, Yves-Marie, Robin, Farid, El Hajbi, Eric, Dansin, Jacques, Bonneterre, Géraldine, Lauridant

Publikováno v: Bulletin du cancer. 105(4)

Primary neuroendocrine breast carcinomas are rare and little-known tumors. Only a limited number of studies on neuroendocrine breast carcinomas have been reported in the literature, and the vast majority of them are small retrospective series or case

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::40c2ea9a2385c60ae470fe79f9374e10
https://pubmed.ncbi.nlm.nih.gov/29567279

MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma

Autor: Margie L. Clapper, Luc Thiberville, Jing Peng, Solène Houlle-Crépin, Douglas B. Flieder, Olivia Abramovici-Roels, Navid A. Roder, Mathieu Salaün, Jean-Christophe Sabourin, Harvey Hensley

Publikováno v: PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (7), pp.e0132960. ⟨10.1371/journal.pone.0132960⟩
PLoS ONE, Vol 10, Iss 7, p e0132960 (2015)

Introduction Several matrix metalloproteinases (MMPs) are overexpressed in lung cancer and may serve as potential targets for the development of bioactivable probes for molecular imaging. Objective To characterize and monitor the activity of MMPs dur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017fce0ffd15c314bc67f8a43e89abf6
https://pubmed.ncbi.nlm.nih.gov/26193700

Genetic Similarities between Ethmoidal Adenocarcinoma and Colorectal Adenocarcinoma: Towards a New Targeted Therapy?

Autor: Olivia Abramovici, Olivier Choussy, re Paviot, Alex, Danièle Dehesdin, Aude Lamy, Jean-Christophe Sabourin

Publikováno v: Journal of Cell Science & Therapy.

Background: To compare the genetic profile and phenotype of sinonasal Intestinal Type AdenoCarcinoma (ITAC) and colorectal adenocarcinoma. Methods: Between 1983 and 2001, 41 patients were treated for ethmoidal adenocarcinoma at Rouen University Hospi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::671105be12d17b018f8ce019c2ffe875
https://doi.org/10.4172/2157-7013.1000157